1. Home
  2. HCTI vs VTGN Comparison

HCTI vs VTGN Comparison

Compare HCTI & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCTI

Healthcare Triangle Inc.

HOLD

Current Price

$0.66

Market Cap

11.4M

Sector

Technology

ML Signal

HOLD

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.29

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCTI
VTGN
Founded
2020
1998
Country
United States
United States
Employees
58
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.4M
10.8M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
HCTI
VTGN
Price
$0.66
$0.29
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
★ $0.90
AVG Volume (30 Days)
2.6M
★ 18.6M
Earning Date
04-16-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $13,891,000.00
N/A
Revenue This Year
$79.33
$124.49
Revenue Next Year
$20.00
$353.99
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 18.77
N/A
52 Week Low
$0.14
$0.20
52 Week High
$9.97
$5.14

Technical Indicators

Market Signals
Indicator
HCTI
VTGN
Relative Strength Index (RSI) 37.66 56.20
Support Level $0.14 $0.22
Resistance Level $1.01 $0.32
Average True Range (ATR) 0.23 0.04
MACD 0.02 0.01
Stochastic Oscillator 1.24 21.15

Price Performance

Historical Comparison
HCTI
VTGN

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their efforts to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Corporate & others.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: